SCHEMBL1101043

SCHEMBL1101043

CCCN(Cc1ccc(COc2ccc(C3CC3C(=O)OC)cc2)cc1)c1nc(-c2ccc(C(F)(F)F)cc2)cs1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 2/20 0.43
ATP4B P51164 2/20 0.43
ALOX5 P09917 2/20 0.42
PSEN1 P49768 2/20 0.42
SMPD1 P17405 1/20 0.41
GCGR P47871 4/20 0.40
GIPR P48546 4/20 0.40
KDM1A O60341 1/20 0.40
MAOB P27338 1/20 0.40
PPARD Q03181 1/20 0.39
FFAR1 O14842 6/20 0.39
SLC6A5 Q9Y345 1/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1100051 0.93 ALOX5 (0.45) ATP4AATP4BALOX5PSEN1GCGR
SCHEMBL1100447 0.92 SMPD1 (0.40) ATP4AATP4BALOX5PSEN1SMPD1
Bicarbonate SCHEMBL16224031 0.86 ATP4A (0.46) ATP4AATP4BALOX5PSEN1GCGR
SCHEMBL1100928 0.85 FFAR1 (0.42) ATP4AATP4BALOX5PSEN1GCGR
SCHEMBL1745385 0.82 PPARD (0.55) ATP4AATP4BALOX5PSEN1GCGR
Bicarbonate SCHEMBL16223879 0.78 ALOX5 (0.41) ATP4AATP4BALOX5PSEN1GCGR
SCHEMBL1100877 0.78 GCGR (0.51) ATP4AATP4BGCGRGIPRALDH1A1
SCHEMBL3917963 0.77 PPARD (0.49) ATP4AATP4BALOX5PSEN1GCGR
SCHEMBL3920620 0.76 PPARD (0.45) ATP4AATP4BALOX5PSEN1SMPD1
SCHEMBL3922019 0.75 ALOX5 (0.47) ATP4AATP4BALOX5PSEN1GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1916234-B1 CYCLOPROPANECARBOXYLIC ACID COMPOUND TAKEDA PHARMACEUTICAL (JP) 2014-11-12 EP disclosed
EP-1916234-B1 CYCLOPROPANECARBOXYLIC ACID COMPOUND TAKEDA PHARMACEUTICAL (JP) 2014-11-12 EP disclosed
US-8153694-B2 Cyclopropanecarboxylic acid compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-10 US disclosed
US-8153694-B2 Cyclopropanecarboxylic acid compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-10 US disclosed
US-8153694-B2 Cyclopropanecarboxylic acid compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-10 US disclosed
US-20100144806-A1 Cyclopropanecarboxylic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-06-10 US disclosed
US-20100144806-A1 Cyclopropanecarboxylic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-06-10 US disclosed
US-20100144806-A1 Cyclopropanecarboxylic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-06-10 US disclosed
EP-1916234-A1 CYCLOPROPANECARBOXYLIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-30 EP disclosed
EP-1916234-A1 CYCLOPROPANECARBOXYLIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144806-A1 Cyclopropanecarboxylic Acid Compound GPR65, GPR34, GPR68 ATP4A 1032/4885ATP4B 3159/4885ALOX5 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.